BCL2 and prostate carcinoma: In the present study, we found that AMP significantly inhibited the proliferation of prostate cancer cell lines via apoptosis induction associated with downregulation of Bcl2 expression, and suppressed prostate cancer cell migration and invasion associated with downregulation of CXCR4 expression in vitro.